Xrf Scientific Limited · ASX:XRF
Xrf Scientific — Shareholder Meeting (February 2016)
16 slides from Xrf Scientific's shareholder meeting presentation, Feb 11, 2016
Slide 1: 2011 Annual General Meeting
2011 Annual General Meeting 30 November 2011
Slide 2: Disclaimer
Disclaimer No responsibility for contents of Investor Presentation •To the maximum extent permitted by law, XRF Scientific Limited and representatives: •make k no representation, t ti warranty t or undertaking, d t ki express or iimplied, li d as tto th the adequacy, d accuracy, completeness l t or
Slide 3: Corporate Snapshot
Corporate Snapshot Structure • Shares on issue: 128,823,764 • Share price: 19.5c • Market k cap: $2$25.1m 1 Directors • Ken Baxter – Non Executive Chairman • Terry Sweet – Managing Director • David Brown – Non Executive Director • John Parsons – Non Executive Director 2,635 20,302 Executive Manageme
Slide 4: Company Overview
Company Overview Manufacturer of consumables and equipment for mining and industry, for X‐Ray Fluorescence (XRF) analysis Offices in Perth and Melbourne with 60 employees across Australia X‐Ray Flux and Platinum Labware Specialised furnaces chemicals and general laboratory equipment 4
Slide 5: Blue Chip Client Base
Blue Chip Client Base al Sl “/060 SGS. GS bhpbilliton ALCOA Rl O \ | NEWCREST TINTO Or Qi CAMPBELL BROTHERS LIMITED Y AvLS Ammtec NA Pasatyia ILUKA
Slide 6: Our Products
scientific XRF Scientific — The vital link in mining and industrial analysis Analysing every tonne XRF Scientific provides a wide range of sophisticated products, services and equipment in order to provide a specialised laboratory supply service. In addition, XRF ‘Scientific also supplies private co
Slide 7: 2011 Operating Highlights
2011 Operating Highlights Acquired Sigma Flux and Precious Metals for $7m total consideration Rebranded operating divisions from old historical name’s to XRF Chemicals, XRF Labware and XRF Technology Greater margins achieved through XRF Chemicals and XRF Labware divisions from economies of sca
Slide 8: 2011 Operating Highlights
2011 Operating Highlights Subsequent Events to 30 June 2011 Acquisition of 19.9% interest in Canadian flux manufacturer Scancia completed in August 2011 Placement and Share Purchase Plan of $4.34m successfully completed in July / August 2011 at 21.5 cents per share The Company is now well posi
Slide 9: FY2011 Financial Results
FY2011 Financial Results Highlights: Revenue up 12.7% on high range of guidance of $18m to $20.3m Profit before tax up 23.3% on high range of guidance of $3m to $3.7m Fully franked dividend of 1 cent per share, paid on 28 October 2011 2011 2010 Actuals Actuals Change $M $M % SSales l revenue 2
Slide 10: FY2011 Financial Results
FY2011 Financial Results Growth Drivers: 2,700 1,228 5,124 1,982 12,478 12,478 522 522 2010 2011 2010 2011 Sales Revenue ($'000) NPBT ($'000) Base amount Organic growth Sigma acquisition 10
Slide 11: FY2011 Divisional Performance
FY2011 Divisional Performance 6,517 3,079 2,961 2,654 Highlights: Acquisition of Sigma Flux completed on 30 July 2011 08 09 10 11 Record demand experienced for the divisions primary product, Sales Revenue ($'000) x‐ray flux, as sample throughput in commercial laboratories were at increased level
Slide 12: FY2011 Divisional Performance
FY2011 Divisional Performance 8,644 7,556 7,016 5,393 Highlights: Acquisition of Sigma Precious Metals completed on 30 July 2011 08 09 10 11 Sales Revenue ($'000) Rapid growth experienced in sale of new labware items 1,538 Increased amount of re‐manufacture and repairs required to used labware
Slide 13: FY2011 Divisional Performance
FY2011 Divisional Performance 6,651 4,931 4,904 3,959 Highlights: 2011 results are in line with the end of a technological cycle of older products, with the cycle forecast to swing back upwards 08 09 10 11 with new products such as the Fusomatic 15 and Robotic Fusion Sales Revenue ($'000) Furnace
Slide 14: FY2012 Outlook
FY2012 Outlook Sales YTD are up strongly on the prior corresponding period (PCP): XRF Chemicals • Total sales revenue for 31/10/2011 / / YTD of $ $2.3m, up 27.8% (PCP: $1.8m) $ • Includes 4 months with Sigma Flux with PCP only including 3 XRF Labware • Total sales revenue for 31/10/2011 YTD of $3
Slide 15: FY2012 Outlook
FY2012 Outlook Improving sales of capital equipment, with a significant technological break through with the “Fusomatic 15” fusion furnace Continue focus of expanding geographically, by increasing sales into areas such as Brazil and Africa Implementation of new accounting / ERP system to help
Slide 16: Questions?
HEF cientific Questions? 16